Comparative assessment of hypercoagulability in women with and without gynecologic malignancies using the thromboelastograph coagulation analyzer

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 2, 2010, Pages 140-143

  Wehrum, Mark J ^a,b   Hines, Jeffrey F ^a   Hayes, Edwin B ^a   Kost, Edward R ^a   Hall, Kevin L ^a   Paidas, Michael J ^b  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gynecologic malignancies; Hypercoagulability; Thromboelastograph coagulation analyzer

Indexed keywords

ADULT; ANALYZER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERCOAGULABILITY; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; THROMBOELASTOGRAPH COAGULATION ANALYZER; THROMBOELASTOGRAPHY; UTERINE CERVIX CANCER; UTERINE TUBE CARCINOMA; VULVA CANCER;

ADULT; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; THROMBELASTOGRAPHY; THROMBOPHILIA;

EID: 76449092266     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283358179     Document Type: Article

References (15)

1. Trousseau A. Phlegmasia alba dolens. Clinique Medicale de l'Hotel de Paris. Anonymous. Balliere; 1865. pp. 654-656.
2. Sporn J, Rickles F. Coagulation abnormalities in cancer patients. Chest 1994; 105:1639-1642.
3. Hartert H. Blutgerninnungstudien mit der thrombelastographic Einen Neven Untersuchingsver Fahren. Klinische Wochenschrift 1948; 16:257-260.
4. Fuchs RJ, Levin J, Tadel M, Merritt W. Perioperative coagulation management in a patient with afibrinogenemia undergoing liver transplantation. Liver Transpl 2007; 13:752.
5. Tanaka KA, Thourani VH, Williams WH, Duke PG, Levy JH, Guyton RA, Puskas JD. Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. J Anesth 2007; 21:297-303.
6. Caprini JA, Traverso CI. Perspectives on thromboelastography. Semin Thromb Hemost 1995; 21 (Sup 4):91-93.
7. Francis JC, Francis DA. Assessment of hypercoagulability in patients with cancer using the sonoclot TM and thromboelastography. Thromb Res 1994; 74:335-346.
8. Haid M. Thromboelastographic distinction of malignant from benign breast masses: a preliminary report. South Med J 1977; 70:774-776.
9. Mallett SV, Cox JA. Thromboelastography. Br J Anaesthesia 1992; 69:307-313.
10. Virchow R. Gesammelte Abhandlungen zur Wissenschaftlichen Medicin. Frankfurt: A. M. Von Meidinger Sohn & Co; 1856. pp. 525-530.
11. Green K, Silverstein R. Hypercoagulability in cancer. Hematol Oncol Clin North Am 1996; 10:499-526.
12. Falanga A, Barbui T, Rickles F. Guidelines for clotting studies in cancer patients. Thromb Haemost 1993; 70:540-542.
13. Anzar J, Soto F, Villa P, Lonjedo L, Bolufer P. Valoracion tromboelastografica de la hiercoagulabilidad plasmatica [Thromboelastographic assessment of plasma hypercoagulability]. Sangre 1979; 24:1-8.
14. Wasowicz M, Coimbatore S, Massimiliano M. Technical report - analysis of citrated blood with thromboelastography: comparison with fresh blood samples. Can J Anesth 2008; 55:284-289.
15. White H, Zollinger C, Jones M, Bird R. Can thromboelastography performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters? Int J Lab Hematol 2009 [Epub ahead of print].